Comparative Pharmacology
Head-to-head clinical analysis: CALOMIST versus CROLOM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALOMIST versus CROLOM.
CALOMIST vs CROLOM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calomist (calcium gluconate) provides calcium ions to stabilize cardiac cell membranes, correct hypocalcemia, and antagonize hyperkalemia-induced cardiotoxicity.
CROLOM is a selective estrogen receptor modulator (SERM) that binds to estrogen receptors, blocking estrogen-mediated signaling in target tissues, thereby inhibiting growth of hormone-sensitive breast cancer cells.
Mist inhalation: 1-2 actuations (100-200 mcg) delivered orally via nebulizer every 6 hours as needed for bronchospasm; maximum 12 actuations per day.
2 capsules (each containing 40 mg cromolyn sodium) orally 4 times daily, 30 minutes before meals and at bedtime.
None Documented
None Documented
Terminal elimination half-life: 4-6 hours; prolonged in renal impairment (up to 20 hours in anuria)
Terminal half-life 8-12 hours in normal renal function; extended to 20-30 hours in severe impairment
Renal: 90% unchanged; biliary/fecal: 10%
Renal: 70% unchanged; biliary/fecal: 30% as metabolites
Category C
Category C
Mast Cell Stabilizer
Mast Cell Stabilizer